Home Cart Sign in  
Chemical Structure| 151358-47-3 Chemical Structure| 151358-47-3

Structure of DIM-C-pPhOH
CAS No.: 151358-47-3

Chemical Structure| 151358-47-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DIM-C-pPhOH is Nur77 antagonist which can induce conformational change.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DIM-C-pPhOH

CAS No. :151358-47-3
Formula : C23H18N2O
M.W : 338.40
SMILES Code : OC1=CC=C(C(C2=CNC3=C2C=CC=C3)C4=CNC5=C4C=CC=C5)C=C1
MDL No. :MFCD03723253
InChI Key :QCPDFNWJBQMXLI-UHFFFAOYSA-N
Pubchem ID :2940609

Safety of DIM-C-pPhOH

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
A549 cells 10 µM and 20 µM 24 hours Caused G0/G1 phase arrest in A549 cells, resulting in 74.46±0.66% and 81.66±0.22% of cells accumulating in G1 phase at 10 μM and 20 μM concentrations, respectively. Eur J Pharm Sci. 2013 Oct 9;50(2):227-41.
Panc-1 cells 25 µM 24 hours Induces ER stress-mediated apoptosis by increasing ROS production Mol Cancer Res. 2014 Apr;12(4):527-538.
MCF-7 breast cancer cells 15 or 20 µM 24 hours To investigate the effect of DIM-C-pPhOH on MCF-7 cell migration, results showed that DIM-C-pPhOH significantly inhibited cell migration. Mol Cell Biol. 2016 Apr 15;36(9):1383-94.
MDA-MB-231 breast cancer cells 15 or 20 µM 24 hours To investigate the effect of DIM-C-pPhOH on MDA-MB-231 cell migration, results showed that DIM-C-pPhOH significantly inhibited cell migration. Mol Cell Biol. 2016 Apr 15;36(9):1383-94.
SKBR3 breast cancer cells 15 or 20 µM 24 hours To investigate the effect of DIM-C-pPhOH on SKBR3 cell migration, results showed that DIM-C-pPhOH significantly inhibited cell migration. Mol Cell Biol. 2016 Apr 15;36(9):1383-94.
Rh30 cells 20 µM 24 hours Induced ROS accumulation and IL-24 expression, inhibited cell proliferation and migration, and induced apoptosis Mol Cancer Res. 2019 Nov;17(11):2221-2232.
RD cells 20 µM 24 hours Induced ROS accumulation and IL-24 expression, inhibited cell proliferation and migration, and induced apoptosis Mol Cancer Res. 2019 Nov;17(11):2221-2232.
MDA-MB-231 cells 20 µM 24 hours DIM-C-pPhOH induced the expression of SERPINB5, GADD45α, and p21 proteins. Breast Cancer Res Treat. 2019 Aug;177(1):29-40.
SKBR3 cells 20 µM 24 hours RNAseq analysis showed that compared to control (DMSO) cells, DIM-C-pPhOH treatment altered the expression of 1823 genes. Breast Cancer Res Treat. 2019 Aug;177(1):29-40.
Colon cancer cells (RKO, SW480) 15 and 20 µM 24 hours Decreased β1-integrin expression, inhibited cell migration and adhesion Mol Carcinog. 2017 Sep;56(9):2066-2075.
Pancreatic cancer cells (Panc1, L3.6pL, MiaPaCa2) 15 and 20 µM 24 hours Decreased β1-integrin expression, inhibited cell migration and adhesion Mol Carcinog. 2017 Sep;56(9):2066-2075.
786-O cells 0-20 µM 24 hours Inhibited cell proliferation, IC50 value was 13.0 μM PLoS One. 2015 Jun 2;10(6):e0128308.
ACHN cells 0-20 µM 24 hours Inhibited cell proliferation, IC50 value was 13.6 μM PLoS One. 2015 Jun 2;10(6):e0128308.
H1299 cells 20 µM 3 days DIM-C-pPhOH inhibited H1299 cell proliferation and induced apoptosis by inactivating the TR3/p300/Sp1 complex. Oncogene. 2012 Jul 5;31(27):3265-76.
H460 cells 20 µM 3 days DIM-C-pPhOH inhibited H460 cell proliferation and mTORC1 signaling through activation of the p53/sestrin2/AMPK α axis. Oncogene. 2012 Jul 5;31(27):3265-76.
A549 cells 20 µM 3 days DIM-C-pPhOH inhibited A549 cell proliferation and mTORC1 signaling through activation of the p53/sestrin2/AMPK α axis. Oncogene. 2012 Jul 5;31(27):3265-76.
L3.6pl cells 15.61 µM (IC50) 48 hours Inhibited cell proliferation and induced apoptosis, accompanied by decreased Bcl-2 and survivin expression, and increased caspase-3 and PARP cleavage Cancer Res. 2010 Sep 1;70(17):6824-36.
MiaPaCa-2 cells 13.87 µM (IC50) 48 hours Inhibited cell proliferation and induced apoptosis, accompanied by decreased Bcl-2 and survivin expression, and increased caspase-3 and PARP cleavage Cancer Res. 2010 Sep 1;70(17):6824-36.
Panc1 cells 11.35 µM (IC50) 48 hours Inhibited cell proliferation and induced apoptosis, accompanied by decreased Bcl-2 and survivin expression, and increased caspase-3 and PARP cleavage Cancer Res. 2010 Sep 1;70(17):6824-36.
A549 cells 10 µM and 20 µM 48 hours Induced apoptosis in A549 cells, resulting in 26±1.05% and 25.5±2.40% apoptosis at 10 μM and 20 μM concentrations, respectively. Eur J Pharm Sci. 2013 Oct 9;50(2):227-41.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice (NCr-nu/nu) Orthotopic model of pancreatic cancer Oral gavage 30 mg/kg Once daily for 4 weeks Inhibited tumor growth and induced apoptosis, accompanied by decreased Bcl-2 and survivin expression, and increased caspase-3 and PARP cleavage Cancer Res. 2010 Sep 1;70(17):6824-36.
Nude mice Orthotopic and metastatic lung cancer models Oral gavage 30 mg/kg 3 times per week for 4 weeks DIM-C-pPhOH significantly inhibited tumor growth in orthotopic and metastatic lung cancer models and induced tumor cell apoptosis. Oncogene. 2012 Jul 5;31(27):3265-76.
Athymic nude mice ACHN cell xenograft model Oral gavage 30 mg/kg Once daily for 50 days Significantly inhibited tumor growth PLoS One. 2015 Jun 2;10(6):e0128308.
Nu/Nu mice A549 cell lung metastasis model Inhalation 5 mg/ml Alternate days for 4 weeks Significantly inhibited lung tumor growth, reduced tumor nodules, and decreased VEGF and CD31 expression, demonstrating anti-angiogenic and anti-metastatic activities. Eur J Pharm Sci. 2013 Oct 9;50(2):227-41.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.96mL

0.59mL

0.30mL

14.78mL

2.96mL

1.48mL

29.55mL

5.91mL

2.96mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories